January 10, 2019
MS treatment now listed on PBS
Mavenclad, a drug used in the treatment of relapsing remitting multiple sclerosis (RRMS), has been listed on the Pharmaceutical Benefits Scheme (PBS) as of January 1. Through the PBS, the government will subsidise almost the entire cost of the drug, saving Australians with RRMS up to $54,000 per year. The treatment has been shown to […]